2026 NPPES data Allergy & Immunology Physician NPI 1043395171 MD
Verify on CMS →

GURVINDER DEOGUN, MD

Allergy & Immunology Physician in RALEIGH, North Carolina. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
568
Medicare Part D claims · 105 beneficiaries · Allergy & Immunology Physician avg: 764
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.5K
97 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: GURVINDER DEOGUN, MD is a Allergy & Immunology Physician ([object Object]) practicing in RALEIGH, North Carolina with a Medicare Part D prescribing footprint of 568 claims across 105 beneficiaries — 45% brand-name prescribing . Industry payments of $2.5K across 97 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: GURVINDER DEOGUN, MD filed 568 Medicare Part D claims in 2023 across RALEIGH, North Carolina. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

GURVINDER DEOGUN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

GURVINDER DEOGUN, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 10/26/2006

NPI 1043395171

Primary specialty

Allergy & Immunology Physician

Niche

3,390 US NPIs in this specialty

Medicare Part D claims

568 26% vs specialty avg

2023 prescription claims

Specialty avg: 764

Specialty distribution in North Carolina

How Allergy & Immunology Physician compares to other specialties among North Carolina providers

North Carolina providers

Allergy & Immunology Physician share within North Carolina

1. Allergy & Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology Physician share within North Carolina

Specialty board-certification context

Estimated specialty board-certified rate — Allergy & Immunology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Allergy & Immunology Physician ABMS/AOA estimate

Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GURVINDER DEOGUN, MD is a Allergy & Immunology Physician provider practicing in RALEIGH, North Carolina, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1043395171. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

GURVINDER DEOGUN, MD appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding MD credentials at 10880 DURANT RD, RALEIGH, NC, 27614, with a listed phone of (919) 846-0800. NPI 1043395171 was issued on 10/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DEOGUN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 568 prescription claims written by this provider, covering 105 Medicare beneficiaries and totaling roughly $260K in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10880 DURANT RD
RALEIGH, NC 27614

Provider Details

NPI 1043395171
Specialty Allergy & Immunology Physician
Credentials MD
Gender Female
NPI Issued 10/26/2006

Hospital and facility affiliations

Facilities where GURVINDER DEOGUN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ALLERGY PARTNERS PLLC
RALEIGH, NC

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GURVINDER DEOGUN, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.5K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

GURVINDER DEOGUN, MD — brand share 45.0%
Specialty average (est.)

45% brand-name claims vs 55% generic, on 568 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

568
Total Claims
$260K
Total Drug Cost
105
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
821
Total Day Supply
22,665
Brand vs Generic
45% brand / 55% generic
Brand Drug Cost
$249K
Generic Drug Cost
$11K

Patient Demographics

Average Patient Age
71.2 years
Avg HCC Risk Score
0.85
Gender Split
68% female / 32% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Montelukast Sodium
62
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
61
Ipratropium Bromide
38
Fluticasone Propionate
32
Azelastine Hcl
29
Epinephrine
29
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
28
Famotidine
26
Prednisone
25
Albuterol Sulfate Hfa
Albuterol Sulfate
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology Physician Overview

How GURVINDER DEOGUN, MD fits within the Allergy & Immunology Physician landscape nationally.

3,390
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
764
Avg Claims per Provider

GURVINDER DEOGUN, MD's 568 claims are below the specialty average of 764.

Nearby Allergy & Immunology Physician Providers in North Carolina

Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as DEOGUN.

Compare Allergy & Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GURVINDER DEOGUN, MD's specialty?
GURVINDER DEOGUN, MD specializes in Allergy & Immunology Physician and practices in RALEIGH, North Carolina. Credentials: MD.
How much does GURVINDER DEOGUN, MD prescribe under Medicare Part D?
In 2023, GURVINDER DEOGUN, MD wrote 568 Medicare Part D claims totaling $260K in drug costs for 105 beneficiaries.
Where is GURVINDER DEOGUN, MD located?
GURVINDER DEOGUN, MD is located at 10880 DURANT RD, RALEIGH, NC, 27614. Phone: (919) 846-0800.
What is GURVINDER DEOGUN, MD's NPI number?
GURVINDER DEOGUN, MD's National Provider Identifier (NPI) is 1043395171, issued on 10/26/2006.
Does GURVINDER DEOGUN, MD prescribe more brand-name or generic drugs?
GURVINDER DEOGUN, MD's prescribing is 45% brand-name and 55% generic drugs by claim count, with $249K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US?
There are 3,390 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 764 Medicare Part D claims per year.
What drugs does GURVINDER DEOGUN, MD prescribe most often?
Based on 2023 Medicare Part D data, GURVINDER DEOGUN, MD's most frequently prescribed drugs include Montelukast Sodium, Trelegy Ellipta, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GURVINDER DEOGUN, MD accept Medicare?
GURVINDER DEOGUN, MD appears in CMS Medicare data with 568 Part D claims and 105 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GURVINDER DEOGUN, MD's credentials?
GURVINDER DEOGUN, MD's NPI is 1043395171 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology